Give value to your projects and investments. Are you maximising your potential?
R&D in Life Sciences and Pharma Research and innovation represent the core of the Life Sciences and Pharma sector. From the lab bench to the manufacturing chain, the R&D efforts of these companies are massive, and they entail significant financial investments. However, many activities and investments carried out in this setting are not taking advantage of the tax relief or R&D incentives that the government has made available. In Belgium, Biotech and Pharma companies, CDMOs, Manufacturing sites, CROs and Regulatory Compliance Offices are well-positioned to be eligible for incentives linked to innovation and R&D. These measures can help offset costs in areas such as staff salaries, equipment, infrastructure expenses, corporate income tax, or copyright tax.
At Leyton, we use our innovation funding expertise to deliver tax relief claims leveraging as an end-to-end service. We follow up with our clients throughout the entire procedure which means that we provide full project management, starting at initial screening engagement and ending with receiving the benefit. Our tax experts have a wealth of experience working with businesses to help them add value to their business through the R&D incentives tax credit programme. These tax experts will combine both elements – both technical and financial reports – enabling your company to successfully benefit from the tax advantages provided by the government.
What are R&D Tax Credits and how can I benefit from them?
Years of Experience
Clients
Talk to our Innovation Funding Specialists